Venture Capital Investors

Tolmar

VC investing group Tolmar provides capital to innovative tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

At Tolmar, science drives everything we do. Through a relentless focus on technology, science, partnership and excellence, we seek to advance patient care and deliver value through innovative therapies and services. The Tolmar portfolio includes specialty products for urology, oncology and dermatology. The invention, development and worldwide approval of ELIGARD® (leuprolide acetate for injectable suspension) delivers innovation and commitment to the urology, oncology and hospital communities, providers and patients. Technology-driven development and high-quality manufacturing capabilities established Tolmar as a leading player for topical generics in the field of dermatology.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/16/2024

Transaction History

Our records indicate that Tolmar invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Anil D'souza

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Tolmar has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Tolero Ventures | Toloka.vc

Share this article

About Our VC Investors Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary